Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Vor Bio Releases New Clinical Data Confirming The Effectiveness Of Shielded Transplants For Delivering Targeted Therapies

Author: Benzinga Newsdesk | September 06, 2024 02:44am

Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefit
VCAR33ALLO demonstrates encouraging biomarker data at lowest dose
New asset VADC45 with significant potential opportunities across oncology, gene therapy, and autoimmune disorders

Posted In: PRTC VOR